News

Tardive Dyskinesia Assessment Workshop members confirm the AIMS to be a valid measure of TD, but recommends alternative analyses to gauge treatments.

One-third of patients with cirrhosis who were also infected with Clostridium difficile were readmitted within 30 days, usually because of recurrent C difficile infection, according to a new nationwide study of hospitalized patients.

Troy Trygstad spoke with MD Magazine ® about the potential for a pandemic flu and emphasized that there’s no “crystal ball” to help predict this.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.

The PA profession has grown nearly 54% in 7 years, particularly in specialties including surgery, emergency medicine, dermatology, and hospital medicine.

How issues with pain in patients with Lyme disease or opioid-induced constipation can be managed in a timely, efficient manner.

Investigators from the University of Adelaide, in Australia, have found that corrected and healthy airway stem cells can replace the ones that cause cystic fibrosis and combat the genetic disorder.

The Childhood Behavior Checklist may help primary care physicians determine if young children are at risk for developing major depressive disorder or anxiety disorders in their teenage and young adult years.

A peer-reviewed manuscript outlines the preclinical validation for the use of QR-110 in the treatment of Leber’s congenital amaurosis 10 (LCA10).

Obsessive compulsive disorder is commonly treated with medicines, psychotherapy, or some combination of the pair. It currently affects about 1% of US adults.

The FDA approved the 2 VMAT-2 drugs for the treatment of tardive dyskinesia in 2017.

A modified 12-week dosing schedule is now available for physicians administering the vascular endothelial growth factor (VEGF) inhibitor to patients with wet age-related macular degeneration.

The SPRINT endura and extensa are cleared for both chronic and acute pain including post-operative pain and post-traumatic pain.

The FDA granted an orphan drug designation to Rafael Pharmaceuticals, Inc.’s CPI-613 for the treatment of peripheral T-Cell lymphoma (PTCL).

The FDA has approved lenvatinib capsules (Lenvima, Eisai Inc.) for first-line treatment of patients with unresectable hepatocellular carcinoma.

For children whose mothers had high levels of a DDT metabolite, the odds of developing autism were one-third higher, and the odds of autism with intellectual disability were double.

A generic version of the 0.3 mg- and 0.15 mg-strength injectors has been approved for the treatment of patients that include those with life-threatening allergic reactions.

A new study has identified a genetic mutation that makes individuals with epidermodysplasia verruciformis more susceptible to human papillomavirus.

New research finds patients hospitalized for alcohol dependence have lower rates of survival if they are also infected with hepatitis C.

Experts argue that oral corticosteroids should be available at home for early use in asthma exacerbation.

The FDA has granted an orphan drug designation and a rare pediatric disease designation to Wave Life Sciences Ltd.’s WVE-210201 for the treatment of Duchenne muscular dystrophy (DMD).

The celebrity chef-turned-producer wants to champion healthcare access, both on the screen and in person. Where does he start?

The results of a new study point to age-related macular degeneration, diabetic retinopathy, and glaucoma as potential early warning signs that an individual is at risk for developing Alzheimer disease or dementia.

The approval is based on data from an ongoing phase 3 open-label safety study of 25 children with CF who have one of 10 mutations in the CFTR gene, in which ivacaftor demonstrated a consistent safety profile.

The FDA has approved ivacaftor (KALYDECO) as the first and only medicine to treat the underlying cause of cystic fibrosis in children ages 12 to

This is the first time that more than one gene has been implicated as the cause of spondylocarpotarsal synostosis syndrome.

The guidelines from the American Academy of Neurology highlight the need to improve diagnosis and ongoing rehabilitative care for patients with disorders of consciousness.

In an effort to reprogram retina cell regeneration, investigators activated dormant stem cells then aided other stem cells in developing into rod photoreceptor cells—the most abundant cell type in the retina which first aid the retina in sensing light.